Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Hany Akkoush
A Phase II Trial of Adjuvant Low-Dose Total Body Irradiation in Non-Hodgkin's Lymphoma Patients Following Standard CHOP
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Related publications
Phase II Trial of Temozolomide in Low-Grade Non-Hodgkin's Lymphoma
British Journal of Cancer
Cancer Research
Oncology
Nuclear Export Inhibition Enhances the Activity of R-Chop in Non-Hodgkin's Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Phase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 With and Following Rituximab in Patients With Recurrent Indolent and Aggressive Non Hodgkin's Lymphoma
Clinical Cancer Research
Cancer Research
Oncology
VEGFandbFGFGene Polymorphisms in Patients With Non-Hodgkin's Lymphoma
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Phase II Trial of High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem-Cell Transplantation for Primary Refractory or Poor-Risk Relapsed Hodgkin's Lymphoma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Autologous SCT With a Dose-Reduced BU and CY Regimen in Older Patients With Non-Hodgkin's Lymphoma
Bone Marrow Transplantation
Transplantation
Hematology
Case Studies of Elderly Patients With Non-Hodgkin's Lymphoma
Hematology Reports
Hematology
A Phase II Study of Bortezomib Added to Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Previously Untreated Indolent Non-Hodgkin's Lymphoma
British Journal of Haematology
Hematology
Adoptive T-Cell Transfer Combined With a Single Low Dose of Total Body Irradiation Eradicates Breast Tumors
OncoImmunology
Oncology
Allergy
Immunology
